IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024


Inhibikase Therapeutics (NASDAQ: ) just reported results for the first quarter of 2024.
InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are…

This story appeared on investorplace.com, .
The Entire Business World on a Single Page. Free to Use →